EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The role of procalcitonin in the follow-up of medullary thyroid cancer

Simona Censi, Jacopo Manso, Teresa Benvenuti, Ilaria Piva, Maurizio Iacobone, Alberto Mondin, Francesca Torresan, Daniela Basso, Gino Crivellari, Stefania Zovato, Caterina Mian iD

European Thyroid Journal · 2023

DOI: 10.1530/etj-22-0161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Thyroid Journal, 2023. Verfasst von Simona Censi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Bone Density Conservation Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Calcitonin (Ct) represents the most important biochemical marker of medullary thyroid cancer (MTC), but has certain limits. We analyzed the performance of procalcitonin (ProCt) in follow-up MTC patients.

Methods

In this monocentric and retrospective study, we consecutively obtained ProCt and Ct values from all MTC patients that we visited during the period from April 2021 to May 2022. Patients were defined as having structural evidence of disease (29/90, 32.2%) irrespective of Ct values or, in its absence, as not evident disease (NED) if Ct was ≤10 ng/L (47/90, 52.2%), or minimal residual disease if Ct was >10 ng/L (14/90, 15.6%).

Results

Ct and ProCt values were highly correlated (r = 0.883, P < 0.01). Median ProCt values differed between NED, minimal residual disease, and structural disease, being 0.04 ng/mL, 0.26 ng/mL, and 1.98 ng/mL, respectively ( P < 0.01). ProCt was undetectable (0.12 ng/mL ( P < 0.01, area under the curve: 0.963), with the following sensitivity, specificity, positive predictive value, and negative predictive value (NPV): 100%, 83.61%, 74.4%, and 100.0%.

Conclusions

ProCt and Ct have a high correlation in MTC follow-up. ProCt may be useful as an adjunct to Ct, especially for its NPV concerning the structural disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsBone Density Conservation AgentsRetrospective StudiesNeoplasm, ResidualHumansCalcium-Regulating Hormones and AgentsCarcinoma, NeuroendocrineFollow-Up StudiesProcalcitonin

Stichwörter der Autor:innen

calcitoninfollow-upmedullary thyroid carcinomaprocalcitonin

Substanzen

ProcalcitoninBone Density Conservation AgentsCalcium-Regulating Hormones and Agents

Autor:innen und Institutionen

  • Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Endocrine Surgery Unit, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padua, Padua, Italy.
  • Laboratory Medicine, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Hereditary Tumor Unit, Istituto Oncologico Veneto, IOV - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padova, Italy.

ORCID-Profile: Caterina Mian

Zitieren

APA

Censi, S., Manso, J., Benvenuti, T., Piva, I., Iacobone, M., Mondin, A., Torresan, F., Basso, D., Crivellari, G., Zovato, S., & Mian, C. (2023). The role of procalcitonin in the follow-up of medullary thyroid cancer. European Thyroid Journal. https://doi.org/10.1530/etj-22-0161

Vancouver

Censi S, Manso J, Benvenuti T, Piva I, Iacobone M, Mondin A, et al. The role of procalcitonin in the follow-up of medullary thyroid cancer. European Thyroid Journal. 2023. doi:10.1530/etj-22-0161

BibTeX
@article{Censi2023,
  author = {Censi, Simona and Manso, Jacopo and Benvenuti, Teresa and Piva, Ilaria and Iacobone, Maurizio and Mondin, Alberto and Torresan, Francesca and Basso, Daniela and Crivellari, Gino and Zovato, Stefania and Mian, Caterina},
  title = {The role of procalcitonin in the follow-up of medullary thyroid cancer},
  journal = {European Thyroid Journal},
  year = {2023},
  doi = {10.1530/etj-22-0161}
}
Kostenlos starten →